Though life sciences companies see value across the full supply chain, it’s the last mile that matters the most to the customer. With this in mind, we surveyed 150+ pharma logistics leaders to learn more about the key
challenges, solutions and trends impacting the last mile of the life
sciences supply chain.
- Analysis of what causes the most last mile disruptions and how firms are addressing these issues
- An overview of our respondents top strategic priorities
- Facts & figures that outline where cold chain leaders are looking to invest in 2018 & 2019
Blockchain & The Temperature Controlled Supply Chain: Is It Time For Pharma Logistics Leaders In Canada to Embrace Blockchain?
As 2019 CCGF Canada speaker Nedal Ismail, Professor and Program Coordinator Bachelor of Commerce, Supply Chain Management & Management Studies, The Business School, Humber Institute of Technology & Advanced Learning, puts it, though "it is not immediately apparent if blockchain will bring an incremental change (i.e. a marginal improvement in existing processes), or a disruptive change (one that will completely change the way the business is conducted), one thing is clear: blockchain stands to transform pharma logistics over the next decade. From enabling increased transparency, security, communication and efficiency, the potential benefits of blockchain seem limitless.
In this in-depth report, we demystify blockchain by shedding light on:
- Current use cases and applications of blockchain in pharma logistics both here in Canada and abroad
- Key barriers to adoption and challenges associated with blockchain
- The future of blockchain technology and how it could potentially be used to optimize the pharma supply chain in years to come
- Why Canada is becoming a global hub for blockchain innovation both within life sciences and beyond